Hepatocellular carcinoma mutation landscape and its differences between Asians and Whites  

作　　者：Xingte Chen Qiao Ke Lei Wang 

机构地区：[1]Department of Radiation Oncology,Clinical Oncology School of Fujian Medical University,Fujian Cancer Hospital,Fuzhou,China [2]Department of Hepatopancreatobiliary Surgery,Clinical Oncology School of Fujian Medical University,Fujian Cancer Hospital,Fuzhou,China

出　　处：《Hepatobiliary Surgery and Nutrition》2022年第5期724-728,共5页肝胆外科与营养（英文）

摘　　要：Hepatocellular carcinoma(HCC)is one of the most common malignancies around the world and accounts for 85%to 90%of the pathological types of primary liver cancer(1).In total,905,677 patients die from HCC,which was the third leading cause of cancer-related death worldwide in 2020(2).Despite significant advancements achieved in early detection,liver transplantation,surgical technique,and local and systemic treatment,the overall prognosis of HCC remains dismal with a 5-year relative survival rate of 18.4%(3).

关 键 词：cancer liver PROGNOSIS 

分 类 号：R735.7[医药卫生—肿瘤]